May 22, 2022·edited May 22, 2022Liked by Alexandros Marinos, Eva Tallaksen
Another great article.
I would suspect most trials (Ivermectin or not) if put under the microscope like this would have similar anomalies if you looked hard enough. The big difference here is the headlines this trial made, perhaps even pro-actively generated by the trial authors (or sponsors) themselves.
In such a setting, the trial therefore deserves to be picked apart at the seams.
You mention the better outcomes seen with the subgroup receiving the first dose within three days of symptoms. Couple this with an analysis excluding all those who received less than 400mcg/kg and I think you would almost certainly get a statistically significant result.
Once you get access to the raw data I’d encourage you to do this analysis.
I don’t think they’ll give you the data though, it may very well mean the end of Ed Mills career as a researcher.
Also, I’d presume Ed and the others involved in this trial are reading every word you write (and these comments) and are quietly panicking.
I’m guessing they’re leaving it as long as possible until they release the data so as to formulate a strategy so as to best defend themselves. Sometimes the best form of defence is attack and therefore they maybe be preparing a strategy to take you down...be careful!
Another great article.
I would suspect most trials (Ivermectin or not) if put under the microscope like this would have similar anomalies if you looked hard enough. The big difference here is the headlines this trial made, perhaps even pro-actively generated by the trial authors (or sponsors) themselves.
In such a setting, the trial therefore deserves to be picked apart at the seams.
You mention the better outcomes seen with the subgroup receiving the first dose within three days of symptoms. Couple this with an analysis excluding all those who received less than 400mcg/kg and I think you would almost certainly get a statistically significant result.
Once you get access to the raw data I’d encourage you to do this analysis.
I don’t think they’ll give you the data though, it may very well mean the end of Ed Mills career as a researcher.
Also, I’d presume Ed and the others involved in this trial are reading every word you write (and these comments) and are quietly panicking.
I’m guessing they’re leaving it as long as possible until they release the data so as to formulate a strategy so as to best defend themselves. Sometimes the best form of defence is attack and therefore they maybe be preparing a strategy to take you down...be careful!
Thank you for persisting. I take great interest in this investigation.
An interesting series of articles.
So many holes in that paper it looks like crochet work